Karakonstantis, S. orcid.org/0000-0002-2643-3184, Rousaki, M., Vassilopoulou, L. et al. (1 more author) (2024) Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia: a systematic review and meta-analysis. Clinical Microbiology and Infection, 30 (2). pp. 178-188. ISSN 1198-743X
Abstract
Background Cefiderocol is a last resort option for carbapenem-resistant (CR) Gram-negative bacteria, especially metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa and CR Acinetobacter baumannii. Monitoring global levels of cefiderocol non-susceptibility (CFDC-NS) is important.
Objectives To systematically collate and examine studies investigating in-vitro CFDC-NS and estimate the global prevalence of CFDC-NS against major Gram-negative pathogens. Data sources PubMed and Scopus, up to May 2023. Study eligibility criteria Eligible were studies reporting CFDC-NS in Enterobacterales, P. aeruginosa, A. baumannii, or Stenotrophomonas maltophilia clinical isolates.
Methods Two independent reviewers extracted study data and assessed risk of bias on the population, setting and measurement (susceptibility testing) domains. Binomial-Normal mixed-effects models were applied to estimate CFDC-NS prevalence by species, co-resistance phenotype and breakpoint definition (EUCAST, CLSI, FDA). Sources of heterogeneity were investigated by subgroup and meta-regression analyses.
Results In all, 78 studies reporting 82,035 clinical isolates were analysed (87% published between 2020 and 2023). CFDC-NS prevalence (EUCAST breakpoints) was low overall, but varied by species [S. maltophilia 0.4% (95%CI 0.2-0.7%), Enterobacterales 3.0% (95%CI 1.5-6.0%), P. aeruginosa 1.4% (95%CI 0.5-4.0%)] and was highest for A. baumannii (8.8%, 95%CI 4.9-15.2%). CFDC-NS was much higher in CR Enterobacterales (12.4%, 95%CI 7.3-20.0%) and CR A. baumannii (13.2%, 95%CI 7.8-21.5%), but relatively low for CR P. aeruginosa (3.5%, 95%CI 1.6-7.8%). CFDC-NS was exceedingly high in NDM-producing Enterobacterales (38.8%, 95%CI 22.6-58.0%), NDM-producing A. baumannii (44.7%, 95%CI 34.5-55.4%), and ceftazidime/avibactam-resistant Enterobacterales (36.6%, 95%CI 22.7-53.1%). CFDC-NS varied considerably with breakpoint definition, predominantly among CR bacteria. Additional sources of heterogeneity were single-centre investigations and geographical regions.
Conclusions CFDC-NS prevalence is low overall, but alarmingly high for specific CR phenotypes circulating in some institutions or regions. Continuous surveillance and updating of global CFDC-NS estimates are imperative while cefiderocol is increasingly introduced into clinical practice. The need to harmonize EUCAST and CLSI breakpoints was evident.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2023 The Authors. Except as otherwise noted, this author-accepted version of a journal article published in Clinical Microbiology and Infection is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ |
Keywords: | carbapenem-resistant; Cefiderocol; drug resistance; global epidemiology; gram-negative bacteria; prevalence |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 07 Sep 2023 09:24 |
Last Modified: | 05 Oct 2024 06:27 |
Status: | Published |
Publisher: | Elsevier BV |
Refereed: | Yes |
Identification Number: | 10.1016/j.cmi.2023.08.029 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:203048 |